Global Continuous Glucose Monitoring Systems (CGMS) Market is Estimated to Reach $6,238 million with CAGR 39.9% from 2016 to 2022 – Acute Market Reports

The global CGMS market $589 million in 2015, and is projected to reach $6,238 million by 2022, registering a CAGR of approximately 39.9% from 2016 to 2022. Real-time continuous glucose monitoring is of utmost importance across all age groups to manage diabetes effectively. Continuous glucose monitoring system (CGMS) enables effective managing of blood glucose levels by providing trend data as well as alarms for the fluctuations in glucose levels.

Browse Full Report Visit – http://www.acutemarketreports.com/report/continuous-glucose-monitoring-systems-market-report

Diabetes, a chronic lifestyle disease, is classified into type 1 and type 2 diabetes. In type 1 diabetes, the pancreas is unable to produce sufficient or requisite amount of insulin hormone, which is required for the breakdown of glucose. It is prevalent in children or young adults and as per the global estimates of International Diabetes Federation (IDF), in 2015, Type 1 diabetes has affected around 542,100 children in the age group below 15 years. Whereas, in type 2 diabetes, the pancreas produce insulin, but the cells do not respond and/or lack the ability to uptake the insulin available in the blood stream. It is the most prevalent type of diabetes, affecting around 8% share of the global population in the age group of 2079 years, which accounts for more than 95% of all types of diabetes.

About 19% of the global healthcare expenditure on diabetes was spent on low- and middle-income groups, which comprise a significant proportion of diabetic patients. On an average, about $5,374 – $9,641 per person was spent by individuals belonging to high-income countries, whereas about $401 – $688 was spent in low- and middle-income countries. It is observed that the U.S. spent about $320 billion of its health budgets for diabetes management, whereas China, with the most number of diabetes population spent about $51 billion on diabetes. The combined healthcare cost of three leading countries, namely U.S., Germany, and China with respect to the prevalence of diabetes is almost 60% of the global healthcare expenditure on diabetes. It can be inferred that people living in low- and middle-income countries spend more on diabetes management as compared to the high-income groups.

This disparity in diabetes healthcare expenditure among high-, low-, and middle-income countries is due to lack of access to health insurance and government-provided medical services.

GLOBAL FINANCIAL BURDEN OF DIABETES, BY GEOGRAPHY, 2015

Furthermore, according to some reports and healthcare experts, about 193 million people, or close to half (46%) of all people with diabetes are undiagnosed, which has led to adverse and costly implications. Thus, it is evident that diabetes management is imperative across all geographical regions and age cohorts in the age group of 5079 years. Measuring/monitoring and managing glucose levels are primary tasks in diabetes management, which can be conducted using glucose monitoring devices.

Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-equipments-market

UNDIAGNOSED PATIENT POPULATION OF DIABETES, 2015 (MILLION)

This can be attributed to the enhanced technological innovations, such as higher convenience offered by CGMS over self-monitoring blood glucose (SMBG) devices, and the detection of hypo- and hyperglycemic events by CGMS. Increase in health awareness and affordability of devices in the developed and developing economies have contributed towards the market growth.

GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION

The global continuous glucose monitoring (CGM) systems market is segmented based on component, end user segment, demographics, and geography. Based on the frequency of use, the CGM components market is sub segmented into sensors, transmitters & receivers, and integrated insulin pumps. Transmitters & receivers coupled with sensors are known as standalone CGM systems, which are preinstalled by OEMs. Sensors are disposable components, which need to be replaced after every 57 days. The report presents data on integrated insulin pumps segment includes insulin pumps integrated with the CGM system, and not individual insulin pumps. Based on end user segment, the market is classified into diagnostics/clinics, ICUs, and home healthcare settings. Based on demographics, the market is divided into child population and adult population. Child population segment includes population in the age group of up to 14 years, whereas adult segment includes population in the age group of above 14years. By geography, this market is studied with respect to four major regionsNorth America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Spain, Italy, Netherlands, Norway, Sweden, Denmark, Finland, and others), Asia-Pacific (Japan, China, India, Australia, South Korea, and others), and LAMEA (Brazil, Venezuela, Saudi Arabia, South Africa, Argentina, and others). The report includes the revenue generated from the sales of these aforementioned categories.

The global CGMS market is still in the developing phase, with CGMS technology being the core sub-set in the value chain of diabetes monitoring devices. Therefore, product development is the key strategy adopted by market players, followed by collaboration. For instance, on September 2016, Abbott received FDA approval for Freestyle Libre Pro System. This system can provide patients ambulatory glucose profile to healthcare professionals.

Acquisition is another key strategy that has been adopted by key companies. Due to the presence of numerous small-sized to mid-sized companies, the larger companies acquire smaller and emergent companies to curb the competition and increase their revenue. For instance,on May 2, 2016, DexCom acquired Nintamed, a distributor company with presence in Switzerland, Germany, and Austria to improve the global access to CGM technologies.

The key players profiled in the report include Abbott Laboratories, Dexcom, Inc., Echo Therapeutics, Inc., GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd. Other players in the CGMS market include (profiles not included in the report) include AgaMatrix, Inc., Arkray USA, Inc., Glucovation, GlySure, OrSense, GlySure, and Pinnacle Technology.

GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET REVENUE, BY GEOGRAPHY

The untapped regions such as Asia-Pacific, Africa, and Latin America are anticipated to emerge as a lucrative market, owing to the presence of large pool of diabetic patients, which makes them highly opportunistic markets for investment, and rise in disposable incomes. Moreover, in highly populous countries, about 8090% of the people with diabetes remain undiagnosed, whereas it is only 30% in high-income countries. The aforementioned factors are expected to boost the growth of the CGMS market in the Asia-Pacific and LAMEA region.

ARGENTINACONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 20142022 ($THOUSAND)

Argentina CGMS devices market is projected to grow at a high CAGR of 43.9% during the forecast period, generating revenue of $3,818 thousand by 2022. The lack of awareness and issues pertaining to price constraints could restrain the market growth. However, supportive government policies, such as spreading awareness and funding or reimbursement for CGM devices would boost the growth of the CMGS market in Argentina.

To Get Complete Report @ http://www.acutemarketreports.com/report/continuous-glucose-monitoring-systems-market-report

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.
  • The market scenario is comprehensively analyzed with respect to the components, demographics, and end user.
  • Comprehensive analysis of the patents is provided to determine the prevailing opportunities.
  • Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
  • In-depth analysis of the market based on geography gives an understanding of the regional market, which assists in strategic business planning.

CGM MARKET KEY SEGMENTS:

The CGMS market is segmented based on component, end user segment, end user demographics, and geography (country-level analysis).

By Component

Sensors
Transmitters & Receivers
Integrated Insulin Pumps

By Demographics

Child Population (=14 years)
Adult Population (>14 years)

By End User

Diagnostics/Clinics
ICUs
Home Healthcare

By Geography

North America

U.S.
Canada
Mexico

Europe

UK
Germany
France
Spain
Italy
Netherlands
Norway
Sweden
Denmark
Finland
Rest of Europe

Asia-Pacific

China
India
Australia
Japan
South Korea
Rest of Asia-Pacific

LAMEA

Brazil
Saudi Arabia
South Africa
Venezuela
Argentina
Rest of LAMEA

Chapter: 1 INTRODUCTION
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO Perspective

Chapter: 3 MARKET OVERVIEW
3.1. Market definition
3.2. Need for glucose monitoring systems
3.2.1. Diabetes–a pandemic
3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and gestational diabetes mellitus (GDM)
3.2.1.4. Gestational diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare expenditure on diabetes
3.3. Technological Advancements IN CGMS
3.3.1.1. Smartphone-connected CGMS
3.3.1.2. Wearable and smartphone-connected CGMS
3.3.1.3. ‘Smart’ diabetes management solution—bionic/artificial pancreas
3.3.1.4. Non-invasive CGMS
3.3.1.5. Invasive CGMS
3.3.2. CGMS: PRIME END USER SEGMENTS
3.3.2.1. CGMS: role in intensive care units (ICUs)

Latest Reports :

Global Surgical Sutures Market 2022

Global PVC Pipe Market 2022

Global Cyber Insurance Market 2022

About – Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com

%d bloggers like this: